Displaying 1 to 20 of 29 investments
| Company | Country | Date | Notes | ||
|---|---|---|---|---|---|
|
ABS Venture VII |
31 Oct 2011 | Fund Closing Active |
||
|
Achaogen Inc Develops solutions to the problem of drug resistance |
United States | N/A Initial investment. Round participant. Active |
||
|
Castlight Health Inc |
United States | 1 May 2012 | Series D Active |
|
|
|
Castlight Health Inc |
United States | 11 Jun 2010 | Series C Active |
|
|
|
Cell Biosciences Inc |
United States | N/A |
||
|
|
Chroma Therapeutics Ltd Focused on harnessing the power of chromatin biology and novel drug accumulation approaches to discover and develop a new generation of targeted cance |
United Kingdom | 3 Apr 2006 | Series C Active |
|
|
|
Dynogen Pharmaceuticals Inc Drug company focused on gastrointestinal and genitourinary disorders. |
United States | N/A |
||
|
|
Intact Medical Corp |
United States | N/A |
||
|
|
Lectus Therapeutics Ltd |
United Kingdom | 1 Sep 2007 | N/A Active |
|
|
|
Pacific Biosciences of California Inc Provider of an integrated platform for genetic analysis. |
United States | 1 Oct 2009 | Series E Active |
|
|
Phononic Inc Developer of solid-state technology for cooling and heating. |
United States | 12 Sep 2016 | N/A Follow-on investment. Round participant. Active |
|
|
|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Jan 2006 | Series B |
||
|
|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Apr 2009 | Series C |
||
|
|
ProteinSimple ProteinSimple's goal is simply to help researchers gain a better understanding of proteins and their role in disease. |
1 Oct 2010 | Series F |
||
|
|
PTC Therapeutics Inc Biopharmaceutical company. |
United States | N/A |
||
|
|
Sapphire Energy Inc |
United States | N/A |
||
|
|
Sequoia Pharmaceuticals Inc Discovers and develops antiviral drugs that inhibits various forms of viruses and prevents the emergence of drug-resistant viruses. |
United States | N/A |
||
|
Siluria Technologies Inc Maker of nanotechnology-enabled products for cleantech-related markets |
United States | 1 Jul 2012 | Series C Active |
|
|
|
Siluria Technologies Inc Maker of nanotechnology-enabled products for cleantech-related markets |
United States | 1 Sep 2011 | Series B Active |
|
|
|
Sirtris Pharmaceuticals Inc |
United States | 1 Dec 2004 | Series A Active |